ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976